
Join to view full profile
888 W Bonneville AveLas Vegas, NV 89106
Phone+1 702-483-6000
Fax+1 702-778-7004
Dr. Hua is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Le Hua is a neurologist based in Las Vegas, NV, specializing in neuroimmunology and multiple sclerosis. She completed her medical education at the Keck School of Medicine of USC, followed by a neurology residency at Stanford and a fellowship in neuroimmunology and multiple sclerosis at the Barrow Neurological Institute. Dr. Hua serves as the Director of the Mellen Program for MS at the Cleveland Clinic Lou Ruvo Center for Brain Health since 2014. She has experience in multiple sclerosis, clinical research, and neuroimaging and has several publications in her field. Additionally, Dr. Hua has been involved in clinical trials and has received multiple CMS Meaningful Use Certifications from Epic Systems Corporation.
Education & Training
Barrow Neurological Institute at St Joseph's Hospital and Medical CenterFellowship, Neuroimmunology & Multiple Sclerosis, 2012 - 2013
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2009 - 2012
University of Arizona College of Medicine-PhoenixInternship, Internal Medicine, 2008 - 2009
Keck School of Medicine of the University of Southern CaliforniaClass of 2008
Valley Hospital Medical CenterResidency, Family Medicine
Certifications & Licensure
AZ State Medical License 2012 - 2028
CA State Medical License 2009 - 2027
NV State Medical License 2013 - 2027
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD Start of enrollment: 2023 Nov 03
Roles: Contact
Publications & Presentations
PubMed
- Tailoring disease-modifying therapy approaches across multiple sclerosis sub-populations.Albert Aboseif, Burcu Zeydan, Nabeela Nathoo, Orhun H Kantarci, Lilyana Amezcua
Multiple Sclerosis and Related Disorders. 2026-09-01 - Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.Evy M Reinders, Ariadna Masot-Llima, Susana Otero-Romero, René Carvajal, Álvaro Cobo-Calvo
Annals of Neurology. 2026-09-01 - Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis.Enrique Alvarez, Robert T Naismith, Le H Hua, Elmor D Pineda, Hela Romdhani
Neurology and Therapy. 2026-08-01
Press Mentions
De-Escalation of Disease-Modifying Therapies in MS: A Real-World Look at OutcomesSeptember 30th, 2025
Diagnosing Pediatric and Late-Onset Multiple SclerosisMarch 17th, 2025
Stop Disease-Modifying Therapy in Stable MS: Yes or No?January 24th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: